Product Images Pralatrexate

Pralatrexate Injection is a medication for intravenous use only. The vial contains 20 mg/mL of Pralatrexate and must be protected from light. It should be refrigerated at 2 to 8° C and not diluted. The recommended dosage is administered as an intravenous push over 3-5 minutes. This medication is for single-dose only and must be stored in the carton until use. The package insert includes further details on administration. Pralatrexate is manufactured for Fresenius-Kabi in Germany.*

This is a product label of Pralatrexate Injection, with NDC number 65219-550-01, manufactured for Fresenius Kabi in Lake Zurich Illinois. No other information apart from the manufacturing location is available.*

This is a description of Pralatrexate Injection, a medication that is intended for intravenous use. Each vial contains a sterile solution of 40 mg/2 mL (20mg/mL) of Pralatrexate and is designed to be used as a single dose only. It contains sodium chloride to produce isotonic solution, and it should not be diluted. The recommended dosage is to be administered as an intravenous push over 3-5 minutes. It is important to store the medication in its carton until use and to protect it from light. This medication is manufactured by Fresenius Kabi in Germany.*

This is a description of a medication labeled as Pralatrexate. It is an injection solution with a concentration of 20mg/mL and a total volume of 2mL, containing 40mg of Pralatrexate. The medication is available only through a prescription (Rx only) and has an NDC code of 65219-552-02. The manufacturer of this medication is Fresenius Kabi and it is manufactured in Lake Zurich, IL.*